Five
years
first
approved
drug
commonly
used
treat
digestive
tract
brand
name
generic
manufacturers
petitioners
also
began
producing
accumulating
evidence
metoclopramide
use
cause
tardive
severe
neurological
warning
labels
drug
strengthened
clarified
several
recently
Respondents
prescribed
received
generic
drug
taking
drug
prescribed
several
developed
tardive
separate
tort
sued
generic
drug
manufacturers
produced
metoclopramide
took
respondent
inter
metoclopramide
use
caused
disorder
Manufacturers
liable
state
tort
law
failing
provide
adequate
warning
Manufacturers
urged
federal
statutes
regulations
state
tort
claims
requiring
safety
efficacy
labeling
generic
metoclopramide
mandated
time
rejected
holding
claims
judgment
cases
reversed
delivered
opinion
respect
concluding
federal
drug
regulations
applicable
generic
drug
manufacturers
directly
conflict
state
analysis
requires
comparison
federal
state
begins
identifying
state
tort
duties
federal
labeling
requirements
applicable
tort
law
requires
manufacturer
aware
danger
label
way
renders
reasonably
Respondents
pleaded
Manufacturers
use
products
carried
high
risk
tardive
dyskinesia
labels
adequately
warn
Taking
allegations
duty
required
Manufacturers
use
stronger
label
one
actually
federal
drug
interpreted
prevented
Manufacturers
independently
changing
generic
safety
manufacturer
seeking
federal
approval
market
new
drug
must
prove
safe
effective
proposed
label
accurate
Although
rules
originally
applied
law
commonly
called
allows
generic
drug
manufacturer
gain
approval
simply
showing
drug
equivalent
safety
efficacy
labeling
proposed
drug
approved
Respondents
contend
federal
law
nevertheless
provides
avenues
Manufacturers
altered
metoclopramide
labels
time
prevent
injuries
permits
drug
without
add
strengthen
warning
sending
letters
providing
additional
warnings
prescribing
physicians
healthcare
denies
Manufacturers
used
either
processes
unilaterally
strengthen
warning
defers
views
plainly
erroneous
inconsistent
reason
doubt
reflect
fair
considered
without
correct
federal
law
nevertheless
required
Manufacturers
ask
assistance
convincing
manufacturer
adopt
stronger
turns
state
federal
law
directly
state
law
must
give
conflict
exists
private
party
comply
state
federal
finds
impossibility
Manufacturers
independently
changed
labels
satisfy
duty
attach
safer
label
generic
violated
federal
requirement
generic
drug
labels
corresponding
drug
impossible
comply
state
federal
even
fulfilled
federal
duty
ask
help
strengthening
corresponding
assuming
duty
satisfied
state
law
demanded
safer
require
communication
possibility
safer
rejects
argument
defense
fails
failed
ask
help
changing
corresponding
proper
question
analysis
whether
private
party
independently
federal
law
state
law
requires
Accepting
argument
render
conflict
largely
meaningless
making
conflicts
state
federal
law
possible
Manufacturers
asked
might
eventually
able
strengthen
warning
also
possible
convinced
reinterpret
regulations
manner
opened
process
persuaded
rewrite
generic
drug
regulations
talked
amending
conjectures
sufficed
prevent
federal
state
law
unclear
outside
express
makes
federal
law
read
permit
approach
renders
conflict
enough
hold
party
satisfy
state
duties
without
special
permission
dependent
exercise
judgment
federal
party
independently
satisfy
state
duties
held
state
tort
action
drug
manufacturer
failure
provide
adequate
warning
label
possible
manufacturer
comply
state
federal
law
federal
statutes
regulations
apply
drug
manufacturers
applicable
generic
drug
different
federal
statutes
regulations
lead
different
distort
order
create
similar
across
dissimilar
statutory
retain
authority
change
law
regulations
delivered
opinion
except
joined
opinion
joined
filed
dissenting
writs
certiorari
courts
appeals
eighth
fifth
circuits
delivered
opinion
Part
consolidated
lawsuits
involve
state
claims
based
certain
drug
alleged
failure
provide
adequate
warning
labels
generic
question
presented
whether
federal
drug
regulations
applicable
generic
drug
manufacturers
directly
conflict
hold
drug
designed
speed
movement
food
digestive
first
approved
metoclopramide
brand
name
Five
years
generic
manufacturers
also
began
producing
drug
commonly
used
treat
digestive
tract
problems
diabetic
gastroparesis
gastroesophageal
reflux
accumulated
metoclopramide
use
cause
tardive
severe
neurological
Studies
shown
patients
take
metoclopramide
several
years
develop
see
also
cases
tardive
dyskinesia
reported
adverse
event
reporting
system
warning
labels
drug
strengthened
clarified
several
label
modified
warn
dyskinesia
may
develop
patients
treated
package
insert
added
longer
weeks
evaluated
see
also
manufacturer
label
change
add
exceed
weeks
ordered
black
box
metoclopramide
cause
tardive
serious
movement
disorder
often
Treatment
metoclopramide
longer
weeks
avoided
rare
plaintiffs
consolidated
prescribed
received
generic
metoclopramide
taking
drug
prescribed
several
women
developed
tardive
separate
sued
generic
drug
manufacturers
produced
metoclopramide
took
relevant
metoclopramide
use
caused
dyskinesia
Manufacturers
liable
state
tort
law
failing
provide
adequate
warning
claimed
mounting
evidence
long
term
metoclopramide
use
carries
risk
tardive
dyskinesia
far
greater
indicated
none
Manufacturers
changed
labels
adequately
warn
see
also
Manufacturers
urged
federal
law
state
tort
According
federal
statutes
regulations
required
use
safety
efficacy
labeling
impossible
simultaneously
comply
federal
law
state
duty
required
use
different
Courts
Appeals
rejected
arguments
held
claims
granted
consolidated
reverse
analysis
requires
us
compare
federal
state
therefore
begin
identifying
state
tort
duties
federal
labeling
requirements
applicable
undisputed
tort
law
require
drug
manufacturer
aware
danger
label
product
way
renders
reasonably
applies
manufacturer
product
actual
constructive
knowledge
danger
manufacturer
duty
give
warning
law
applicable
duty
warn
includes
duty
provide
adequate
instructions
safe
use
see
also
duty
warn
falls
specifically
pleaded
Manufacturers
knew
known
high
risk
tardive
dyskinesia
inherent
use
also
pleaded
Manufacturers
knew
known
labels
adequately
warn
parties
dispute
allegations
state
law
required
Manufacturers
use
safer
law
imposes
far
complex
drug
labeling
begin
Amendments
manufacturer
seeking
federal
approval
market
new
drug
must
prove
safe
effective
proposed
label
accurate
requirements
involves
costly
lengthy
clinical
see
also
rules
applied
passed
commonly
called
gain
approval
simply
showing
equivalence
reference
listed
drug
already
approved
allows
manufacturers
develop
generic
drugs
without
duplicating
clinical
trials
already
performed
equivalent
generic
drug
application
must
also
safety
efficacy
labeling
proposed
labeling
approved
see
also
generic
drug
manufacturers
different
federal
drug
labeling
manufacturer
seeking
new
drug
approval
responsible
accuracy
adequacy
manufacturer
seeking
generic
drug
responsible
ensuring
warning
label
brand
parties
dispute
generic
manufacturers
may
change
labels
initial
contend
federal
law
provided
several
avenues
Manufacturers
altered
metoclopramide
labels
time
prevent
injuries
tells
us
interprets
regulations
require
warning
labels
drug
generic
copy
must
always
generic
drug
manufacturers
ongoing
federal
duty
see
also
generic
labeling
must
listed
drug
labeling
listed
drug
product
basis
generic
drug
views
unless
plainly
erroneous
inconsistent
reason
doubt
reflect
fair
considered
quotation
marks
urge
process
allowed
Manufacturers
change
labels
see
also
process
permits
drug
manufacturers
strengthen
strengthen
instruction
dosage
administration
intended
increase
safe
use
drug
making
labeling
changes
using
drug
need
wait
preapproval
ordinarily
necessary
change
need
simultaneously
file
supplemental
application
denies
Manufacturers
used
process
unilaterally
strengthen
warning
agency
interprets
regulation
allow
changes
generic
drug
labels
generic
drug
manufacturer
changes
label
match
updated
label
follow
argues
changes
unilaterally
made
strengthen
generic
warning
label
violate
statutes
regulations
requiring
generic
label
match
see
also
may
withdrawn
generic
label
longer
consistent
defer
interpretation
generic
labeling
Although
offer
ways
interpret
see
find
interpretation
erroneous
inconsistent
quotation
marks
suggest
reason
doubt
therefore
conclude
process
open
Manufacturers
sort
change
required
state
contend
Manufacturers
used
letters
send
warnings
prescribing
physicians
healthcare
defer
argues
letters
qualify
see
also
letters
must
contrary
approved
letter
contained
substantial
new
warning
information
consistent
approved
generic
drug
sent
inaccurately
imply
therapeutic
difference
brand
generic
drugs
impermissibly
see
may
withdraw
approval
generic
drug
labeling
drug
false
misleading
defer
offer
argument
interpretation
plainly
conclude
federal
law
permit
Manufacturers
issue
additional
warnings
Though
denies
Manufacturers
used
process
letters
strengthen
warning
agency
asserts
different
avenue
existed
changing
generic
drug
According
required
warning
labels
agency
believed
warnings
agreed
label
change
worked
manufacturer
create
new
label
generic
agency
traces
duty
provides
drug
unless
labeling
bears
adequate
warnings
unsafe
dosage
methods
duration
administration
manner
necessary
protection
interpreted
statute
require
revised
include
warning
soon
reasonable
evidence
association
serious
hazard
According
requirements
apply
premise
federal
drug
regulation
manufacturer
bears
responsibility
content
label
reconciles
duty
adequate
accurate
labeling
duty
sameness
following
drug
manufacturers
become
aware
safety
problems
must
ask
agency
work
toward
strengthening
label
applies
generic
equivalent
Manufacturers
disagree
whether
alleged
duty
request
strengthened
label
actually
argues
explained
duty
preamble
regulations
implementing
see
generic
drug
manufacturer
believes
new
safety
information
added
contact
determine
whether
labeling
generic
listed
drugs
claim
statement
create
generic
drug
manufacturer
ever
acting
pursuant
See
ultimately
find
even
assuming
duty
resolve
relevant
state
federal
requirements
tort
law
places
duty
directly
drug
manufacturers
adequately
safely
label
Taking
allegations
duty
required
Manufacturers
use
stronger
label
label
actually
drug
interpreted
prevented
Manufacturers
independently
changing
generic
safety
federal
law
also
required
Manufacturers
ask
assistance
convincing
manufacturer
adopt
stronger
corresponding
generic
drug
manufacturers
turn
question
establishes
federal
law
state
federal
law
state
law
must
give
concurring
see
also
law
naturally
preempted
extent
conflict
federal
held
state
federal
law
conflict
private
party
comply
state
federal
quotation
marks
find
impossibility
lawful
federal
law
Manufacturers
state
law
required
even
fulfilled
federal
duty
ask
satisfied
requirements
state
Manufacturers
independently
changed
labels
satisfy
violated
federal
Taking
allegations
state
law
imposed
duty
attach
safer
label
generic
demanded
drug
labels
times
drug
impossible
Manufacturers
comply
duty
change
label
federal
law
duty
keep
label
federal
duty
ask
help
strengthening
corresponding
assuming
duty
change
Although
requesting
assistance
satisfied
federal
satisfied
state
duty
provide
adequate
law
demanded
safer
instruct
Manufacturers
communicate
possibility
safer
deny
state
tort
claims
based
alleged
failure
ask
assistance
changing
federal
drug
medical
device
laws
state
claim
based
failure
properly
communicate
contend
claims
turn
whether
asked
assistance
changing
federal
affirmative
defense
argue
Manufacturers
asked
help
changing
corresponding
might
eventually
able
accomplish
federal
law
state
law
true
Manufacturers
asked
done
decided
sufficient
supporting
undertook
negotiations
adequate
label
changes
decided
Manufacturers
started
game
eventually
led
better
label
generic
raises
novel
question
whether
conflict
take
account
possible
actions
federal
law
permitted
Manufacturers
even
absent
change
law
depending
actions
law
dictate
text
generic
rather
ties
labels
federal
law
permit
Manufacturers
comply
state
labeling
requirements
manufacturer
changed
label
assert
private
ability
comply
state
law
depends
approval
assistance
proving
requires
party
demonstrate
allowed
compliance
state
bear
burden
proving
impossibility
even
try
start
process
might
ultimately
allowed
use
safer
fair
reject
question
whether
private
party
independently
federal
law
state
law
requires
defendant
state
law
argument
render
conflict
largely
meaningless
make
conflicts
state
federal
law
often
imagine
third
party
Federal
might
something
makes
lawful
private
party
accomplish
federal
law
state
law
requires
certainly
possible
Manufacturers
asked
might
eventually
able
strengthen
warning
also
possible
Manufacturers
convinced
reinterpret
regulations
manner
opened
process
Following
argument
logical
also
possible
Manufacturers
persuaded
rewrite
generic
drug
regulations
entirely
talked
amending
conjectures
suffice
prevent
federal
state
law
conflicting
unclear
outside
express
read
permit
approach
renders
conflict
makes
federal
law
even
absent
express
statement
text
federal
law
Thing
contemplates
conflict
describing
federal
law
effectively
repealing
contrary
state
see
discussion
state
ratification
debates
concerning
whether
federal
law
repeal
state
vice
phrase
state
law
non
legislatures
used
non
obstante
provisions
specify
degree
new
statute
meant
repeal
potentially
conflicting
statutes
dozens
statutes
similar
non
obstante
provision
new
statute
acknowledged
statute
might
contradict
prior
law
instructed
courts
apply
general
presumption
implied
two
Acts
seemingly
yet
non
possible
latter
may
former
non
obstante
provision
therefore
suggests
federal
law
understood
impliedly
repeal
conflicting
state
provision
suggests
courts
strain
find
ways
reconcile
federal
law
seemingly
conflicting
state
courts
went
great
lengths
attempting
harmonize
conflicting
order
avoid
implied
seek
construction
reconcile
statutes
fair
course
reasoning
two
statutes
repugnance
quite
finding
implied
non
obstante
provision
useful
way
legislatures
specify
want
courts
distorting
new
law
accommodate
see
also
inserted
statute
provision
non
obstante
supposed
courts
less
inclined
recognizing
repugnancy
applying
two
one
appearance
crossing
clause
non
obstante
contained
second
statute
exposition
stand
seeming
variance
two
clause
non
obstante
construction
made
may
non
obstante
provision
indicates
need
look
ordinary
federal
distort
federal
law
accommodate
conflicting
state
concurring
quotation
marks
consider
analysis
contingencies
inherent
ability
comply
state
law
depended
uncertain
federal
agency
inconsistent
non
obstante
provision
required
continually
prove
counterfactual
conduct
manufacturer
order
establish
supremacy
federal
think
contemplates
sort
contingent
non
obstante
provision
suggests
analysis
involve
speculation
ways
federal
agency
actions
potentially
reconcile
federal
duties
conflicting
state
federal
law
blocks
private
party
independently
accomplishing
state
law
party
established
whether
private
party
act
sufficiently
independently
federal
law
state
law
requires
may
sometimes
difficult
Manufacturers
satisfy
state
federal
undertake
special
effort
permitting
decide
enough
hold
party
satisfy
state
duties
without
special
permission
dependent
exercise
judgment
federal
party
independently
satisfy
state
duties
state
law
imposed
duty
Manufacturers
take
certain
federal
law
barred
taking
action
Manufacturers
independently
matter
tort
claims
plaintiff
contended
drug
manufacturer
breached
state
duty
provide
adequate
warning
held
lawsuit
possible
drug
comply
state
federal
permitted
drug
manufacturer
like
unilaterally
strengthen
without
prior
federal
regulations
applicable
allowed
strengthen
label
compliance
state
tort
recognize
perspective
finding
makes
little
taken
drug
prescribed
control
lawsuits
acting
full
accord
state
substituted
generic
metoclopramide
federal
law
pharmacists
may
substitute
acknowledge
unfortunate
hand
federal
drug
regulation
dealt
others
similarly
task
decide
whether
statutory
scheme
established
unusual
even
concurring
part
dissenting
quotation
marks
brackets
beyond
dispute
federal
statutes
regulations
apply
drug
manufacturers
meaningfully
different
apply
generic
drug
regulation
generic
drugs
allowed
generic
drug
market
bringing
drugs
quickly
cheaply
different
federal
statutes
regulations
lead
different
distort
order
create
similar
across
dissimilar
statutory
retain
authority
change
law
regulations
judgments
cases
remanded
proceedings
consistent
writs
certiorari
courts
appeals
eighth
fifth
circuits
today
invokes
doctrine
impossibility
hold
federal
law
immunizes
manufacturers
claims
unilaterally
change
traditionally
held
defendants
claiming
impossibility
demanding
mere
possibility
impossibility
enough
establish
manufacturers
propose
label
change
believe
labels
agrees
labels
initiate
change
triggering
corresponding
change
generic
generic
manufacturer
full
compliance
federal
law
duty
Although
generic
manufacturers
may
able
show
impossibility
generic
manufacturers
metoclopramide
shown
might
unable
comply
federal
law
duties
warn
respondents
insufficient
sustain
strains
reach
opposite
invents
new
principles
law
thin
air
justify
dilution
impossibility
effectively
rewrites
decision
holds
federal
law
claims
drug
plurality
tosses
aside
repeated
admonition
courts
hesitate
conclude
intended
state
laws
governing
health
result
whether
consumer
harmed
inadequate
warnings
obtain
relief
turns
solely
happenstance
whether
pharmacist
filled
prescription
generic
gets
one
thing
outcome
little
decision
affects
percent
prescription
drugs
dispensed
dominant
position
generic
drugs
prescription
drug
market
result
series
legislative
federal
enacted
known
Amendments
available
low
cost
generic
drugs
establishing
generic
drug
approval
majority
accomplish
goal
amendments
establish
abbreviated
application
process
generic
see
also
abbreviated
approval
process
implements
core
principle
generic
drugs
must
nearly
obtain
generic
manufacturer
must
ordinarily
among
product
active
ingredients
approved
route
dosage
strength
new
drug
product
eliminating
need
generic
manufacturers
prove
safety
efficacy
Amendments
allow
generic
manufacturers
bring
drugs
market
much
less
also
acted
expand
consumption
generic
years
leading
passage
enacted
legislation
authorizing
pharmacists
substitute
generic
drugs
filling
prescriptions
form
generic
substitution
require
generic
substitution
certain
Expanding
Expanding
Others
Expanding
require
patient
consent
physician
specify
brand
name
must
although
different
levels
effort
Expanding
legislative
efforts
expand
production
consumption
generic
drugs
proved
wildly
estimated
Amendments
generic
drugs
constituted
percent
drugs
sold
Congressional
Increased
Affected
Prices
dominate
Expanding
drugs
constituted
percent
dispensed
prescription
drugs
percent
drugs
generic
version
available
filled
many
generic
versions
drug
enter
manufacturer
stops
selling
drug
See
Brief
studies
showing
anywhere
generic
drugs
longer
marketed
Reflecting
success
many
generic
including
Manufacturers
multinational
generic
drug
manufacturers
sold
estimated
billion
drugs
country
obtain
approval
generic
manufacturer
must
generally
show
drug
approved
need
conduct
clinical
trials
prove
safety
efficacy
generic
manufacturer
duty
federal
law
ensure
safety
limited
resources
conduct
postapproval
monitoring
drug
superior
access
information
especially
postmarketing
phase
new
risks
law
obliges
drug
monitor
safety
federal
generic
manufacturers
must
written
procedures
reporting
postmarketing
adverse
drug
see
also
applicable
generic
must
review
reports
adverse
drug
experiences
received
manufacturer
receives
report
serious
unexpected
adverse
drug
must
event
within
days
must
see
also
adverse
drug
experiences
must
reported
quarterly
yearly
manufacturers
must
also
submit
annual
report
summarizing
new
information
previous
year
might
affect
labeling
drug
including
actions
manufacturer
taken
intends
take
result
new
see
also
majority
also
bear
responsibility
federal
law
monitoring
adequacy
agree
conclusion
generic
manufacturers
permitted
unilaterally
change
labels
process
issue
additional
warnings
According
generic
manufacturers
disseminate
additional
warnings
mean
federal
law
permits
remain
idle
conclude
labeling
regulations
require
labeling
revised
include
warning
soon
reasonable
evidence
association
serious
hazard
currently
codified
see
also
construes
regulation
oblige
generic
manufacturers
seek
revise
labeling
provide
supporting
information
believe
additional
warnings
Manufacturers
read
regulation
require
ensure
labels
match
need
decide
whether
regulation
fact
obliges
generic
manufacturers
approach
propose
label
majority
assumes
even
generic
manufacturers
duty
propose
label
two
points
remain
duty
federal
law
monitor
safety
may
approach
propose
label
change
believe
change
brings
law
obliged
Manufacturers
warn
dangers
Manufacturers
majority
federal
law
claims
federal
provided
additional
warnings
respondents
without
exercise
judgment
endorse
novel
conception
impossibility
Two
principles
guide
purpose
ultimate
touchstone
every
particularly
legislated
field
traditionally
start
assumption
historic
police
powers
superseded
unless
clear
manifest
purpose
internal
quotation
marks
alterations
principles
find
particular
resonance
traditionally
regulated
health
safety
Notwithstanding
awareness
prevalence
state
tort
drug
expressly
tort
actions
prescription
drug
whether
amended
powers
public
reliability
took
care
preserve
state
see
amendments
made
construed
invalidating
provision
law
valid
absence
amendments
unless
direct
positive
conflict
amendments
provision
although
enacted
express
provision
medical
devices
see
included
provision
eight
years
issue
powerful
evidence
intend
oversight
exclusive
means
ensuring
drug
safety
law
impliedly
state
law
state
federal
law
impossible
private
party
comply
state
federal
state
law
obstacle
accomplishment
execution
full
purposes
objectives
quotation
marks
rely
solely
former
ground
affirmative
defendant
seeking
set
aside
state
law
bears
burden
prove
prevail
defendant
must
demonstrate
federal
state
law
physical
see
also
must
federal
state
existence
hypothetical
potential
conflict
insufficient
state
see
also
concurring
part
concurring
mere
possibility
impossibility
contend
impossible
provide
additional
warnings
respondents
federal
law
prohibited
changing
labels
asked
initiate
label
agreed
label
change
indeed
manufacturer
change
triggering
corresponding
change
generic
Manufacturers
invoked
available
mechanism
initiating
label
may
well
able
change
labels
sufficient
time
warn
failed
Manufacturers
sustain
burden
least
without
factual
demonstrate
impossible
comply
federal
state
demonstrated
hypothetical
potential
Like
Manufacturers
focus
fact
change
labels
distinguishes
defendant
correctly
point
concluded
regulation
authorized
defendant
strengthen
warnings
receiving
agency
approval
supplemental
application
describing
label
see
also
label
change
contingent
retained
reject
labeling
changes
made
pursuant
long
compliance
duty
warn
required
action
two
manufacturer
change
label
reviewing
supplemental
agree
need
approval
label
change
make
compliance
federal
state
law
impossible
every
defendant
bore
burden
show
required
produce
evidence
approved
change
apply
approach
respondents
required
Manufacturers
provide
strengthened
warning
dangers
metoclopramide
like
manufacturer
available
mechanism
attempting
comply
duty
law
necessarily
impossible
Manufacturers
comply
federal
state
law
approached
may
well
agreed
label
change
require
Manufacturers
show
approved
proposed
label
made
argue
attempted
give
kind
warning
required
state
law
prohibited
say
generic
manufacturers
never
show
defendant
proposed
label
change
rejected
impossible
defendant
comply
duty
impossibility
established
yet
responded
generic
request
label
change
time
injuries
generic
manufacturer
might
also
show
considered
whether
request
enhanced
warnings
light
evidence
claim
rests
decided
leave
warnings
make
argument
questions
fact
established
burden
proving
impossibility
falls
hold
federal
law
render
impossible
generic
manufacturers
comply
duty
warn
categorical
conclusion
flows
naturally
overarching
governing
sovereigns
federal
leads
us
assume
cavalierly
causes
reason
hold
defendants
asserting
impossibility
presumption
particular
force
afforded
defendants
mechanism
complying
state
even
mechanism
requires
federal
agency
presumption
even
greater
force
federal
law
requires
defendants
invoke
majority
assumes
defendants
usually
unable
sustain
burden
showing
impossibility
even
attempted
employ
approach
threatens
infringe
authority
traditional
matters
state
claims
expressed
intent
state
majority
concedes
Manufacturers
might
able
accomplish
federal
law
state
law
reach
conclusion
Manufacturers
nonetheless
satisfied
show
majority
invents
new
question
whether
private
party
independently
federal
law
state
law
requires
Manufacturers
changed
labels
without
exercise
judgment
majority
compliance
state
federal
law
impossible
new
test
basis
majority
cites
support
discussed
stand
proposition
impossible
comply
federal
state
law
whenever
federal
agency
approval
label
changes
manufacturers
subject
review
even
characterized
turning
fact
manufacturer
change
label
possibility
unilateral
action
sufficient
condition
rejecting
impossibility
defense
hold
unilateral
action
necessary
condition
every
little
support
case
majority
turns
None
rationales
makes
offers
reductio
ad
possibility
approval
label
change
sufficient
avoid
conflict
possibility
might
rewrite
regulations
might
amend
logic
conclusion
escapes
analysis
necessarily
turns
existing
ridiculous
conclude
federal
state
law
conflict
ground
defendant
asked
federal
agency
change
compliance
duty
warn
ask
change
federal
majority
See
law
permit
Manufacturers
comply
state
labeling
requirements
manufacturer
changed
label
already
afforded
mechanism
attempting
comply
majority
assumes
regulations
required
Manufacturers
request
label
change
evidence
association
serious
hazard
majority
suggests
approach
render
conflict
expresses
concern
without
robust
view
constitutes
except
cases
express
extent
purported
concern
driven
reductio
ad
see
concern
reasons
extent
majority
concerned
traditionally
narrow
view
constitutes
impossibility
somehow
renders
conflict
whole
concern
simply
makes
repeatedly
recognized
conflict
may
even
absent
state
law
obstacle
accomplishment
execution
full
purposes
objectives
quotation
marks
expansive
view
impossibility
unnecessary
prevent
conflict
losing
plurality
adopts
novel
theory
intended
operate
non
obstante
According
non
obstante
provisions
statutes
courts
apply
general
presumption
implied
quotation
marks
see
also
statute
contains
non
obstante
less
inclined
recognizing
repugnancy
applying
understanding
plurality
extrapolates
principle
strain
find
ways
reconcile
federal
law
seemingly
conflicting
state
principle
news
enacted
Amendments
precedents
hold
half
directed
courts
presume
congressional
action
supersede
historic
police
powers
unless
clear
manifest
purpose
see
also
concurring
part
concurring
apply
presumption
spoken
question
context
express
read
federal
statutes
whenever
possible
state
See
text
clause
susceptible
one
plausible
courts
ordinarily
reading
disfavors
see
also
claim
federal
law
impliedly
state
require
showing
conflict
overcome
presumption
state
local
regulation
constitutionally
coexist
federal
new
theory
direct
assault
long
presumed
federal
law
state
plurality
today
reads
operate
provision
instructing
courts
apply
general
presumption
implied
quotation
marks
emphasis
whereas
long
required
evidence
purpose
plurality
instructs
courts
ordinary
meaning
federal
concluding
must
intended
cast
aside
state
quotation
marks
alteration
plurality
finds
necessary
resort
novel
theory
theory
advocated
party
amici
application
longstanding
presumption
compels
conclusion
federal
law
render
compliance
state
law
impossible
merely
requires
actor
seek
federal
agency
federal
law
provides
actors
attempting
comply
sovereigns
federal
require
actors
attempt
comply
state
law
heard
complain
compliance
laws
decision
leads
many
absurd
consequences
fathom
intended
state
law
analysis
strips
consumers
compensation
injured
inadequate
intended
deprive
injured
parties
long
available
form
surely
expressed
intent
longstanding
existence
product
liability
including
failure
difficult
believe
without
remove
means
judicial
recourse
injured
illegal
see
also
previously
expressed
quietly
preempt
claims
without
providing
federal
concluding
silently
immunized
generic
manufacturers
majority
disregards
previous
hesitance
infer
congressional
intent
effect
sweeping
change
traditional
majority
drug
right
compensation
inadequate
warnings
turns
happenstance
whether
pharmacist
filled
drug
consumer
takes
sue
manufacturer
inadequate
warnings
opinion
takes
generic
occurs
percent
right
majority
offers
reason
new
articulation
impossibility
intended
arbitrary
pharmacists
must
dispense
generic
drugs
absent
instruction
contrary
Even
consumers
request
price
drug
insurance
plans
may
make
impossible
many
consumers
ability
preserve
right
recover
injuries
caused
inadequate
decision
creates
gap
parallel
regulatory
scheme
way
troubling
consequences
drug
explained
tort
suits
uncover
unknown
drug
hazards
provide
incentives
drug
manufacturers
disclose
safety
risks
law
offers
layer
consumer
protection
complements
decision
eliminates
traditional
incentives
generic
manufacturers
monitor
disclose
safety
generic
drug
equivalent
manufacturer
remain
incentivized
uncover
safety
manufacturers
often
leave
market
generic
versions
see
meaning
manufacturer
subject
generic
layer
consumer
decision
undoes
core
principle
Amendments
generic
drugs
nearly
majority
pins
expansion
generic
drug
market
regulation
generic
allows
generic
manufacturers
produce
drugs
tells
half
expansion
market
generic
drugs
also
flowed
increased
acceptance
trust
generic
drugs
state
legislators
decision
introduces
critical
distinction
generic
Consumers
drugs
sue
manufacturers
inadequate
consumers
generic
drugs
divergent
liability
rules
threaten
reduce
consumer
demand
least
among
consumers
afford
may
pose
ethical
prescribing
may
well
cause
rethink
longstanding
efforts
promote
generic
use
generic
substitution
generic
substitution
laws
proceeded
premise
generic
drugs
materially
different
brand
except
lower
consequences
directly
odds
goal
increasing
consumption
generic
Nothing
opinion
convinces
enacting
requirement
generic
labels
match
corresponding
intended
absurd
certainly
shown
manifest
purpose
quotation
marks
emphasis
federal
law
affords
generic
manufacturers
mechanism
attempting
comply
duties
hold
federal
law
categorically
claims
generic
light
presumption
burden
fall
generic
manufacturers
show
compliance
impossible
particular
facts
holding
insufficient
contorts
doctrine
exempts
defendants
burden
establish
FOOTNOTES
Together
also
certiorari
certiorari
joins
relevant
events
cases
predate
therefore
refer
exclusively
statutes
regulations
express
view
impact
use
refers
drug
designed
copy
reference
listed
drug
identical
active
listed
brief
filed
represents
views
Although
defer
interpretation
defer
ultimate
conclusion
whether
state
law
address
whether
state
federal
law
circumstances
beyond
concurring
contain
provision
expressly
state
tort
contain
saving
clause
expressly
preserve
state
tort
concurring
saving
clause
Although
express
statement
always
lack
statement
end
absence
express
reason
find
conflict
dissent
asserts
forgetting
dissent
form
conflict
conflict
analysis
must
take
account
hypothetical
federal
including
possible
changes
Acts
little
reason
think
based
purposes
objectives
survive
also
urged
state
tort
law
unacceptable
accomplishment
execution
full
purposes
objectives
rejected
type
argued
retained
authority
eventually
rescind
unilateral
noted
attempted
rescinded
change
label
thereby
demonstrate
fact
impossible
federal
law
state
law
offered
analysis
consistent
holding
asked
drug
manufacturer
independently
federal
absence
clear
evidence
accomplished
state
law
required
found
held
federal
law
accommodated
state
law
possibility
see
also
federal
law
directly
conflicts
state
analysis
necessarily
turns
existing
question
cases
whether
possibility
impossibility
establishes
rather
whether
possibility
possibility
defeats
dissent
overstates
characterizes
absurd
us
practical
genuinely
new
information
drugs
long
use
generic
drugs
typically
appears
patent
protections
ordinarily
prevent
generic
drugs
arriving
market
number
years
drug
situations
like
one
alleged
apparently
rare
establishing
generic
drug
duty
initiate
label
regulation
setting
dissent
admits
even
generic
drug
manufacturers
establish
number
materials
visited
available
case
many
insurance
plans
structured
promote
generic
Effects
Using
online
programs
similarly
promote
generic
online
adverse
drug
experience
defined
adverse
event
associated
use
drug
whether
considered
drug
Like
refer
statutes
congressional
hearings
representatives
generic
drug
manufacturers
confirmed
obligation
ability
conduct
postapproval
investigation
adverse
drug
chairman
manufacturers
sensitive
importance
looking
adverse
provide
whatever
required
performed
meet
regulatory
requirement
provide
safety
using
role
obligation
executive
officer
president
single
generic
drug
company
know
large
research
researches
drug
bringing
market
researches
new
researches
adverse
construction
regulation
mirrors
guidance
provided
generic
manufacturers
nearly
years
ago
announcing
final
rule
implementing
abbreviated
application
process
generic
application
approval
generic
drug
applicant
believes
new
safety
information
added
contact
determine
whether
labeling
generic
listed
drugs
approval
holder
believes
new
safety
information
provide
adequate
supporting
information
determine
whether
labeling
generic
listed
drugs
internal
procedures
recognize
consult
components
labeling
Policies
Procedures
Consultations
involving
serious
safety
receive
highest
decision
suggested
Manufacturers
show
impossibility
federal
law
merely
permitted
sell
generic
require
See
generic
defendants
compelled
market
realized
label
insufficient
believe
even
propose
label
simply
stopped
selling
see
also
American
case
one
state
law
penalizes
federal
law
Respondents
advanced
find
unnecessary
time
cause
action
authority
require
manufacturer
change
received
authority
equally
significant
authority
withdraw
permission
market
drug
manufacturer
refused
make
requested
labeling
ability
comply
duty
warn
depend
unilateral
actions
period
changed
label
approved
disapproved
label
claim
appear
arisen
claim
Manufacturers
required
ask
assistance
changing
role
arises
result
cases
involve
situation
manufacturer
produces
generic
Era
see
also
Questions
companies
make
half
generic
manufacturer
independently
change
label
triggering
corresponding
change
generic
author
previously
expressed
view
obstacle
inconsistent
concurring
concurring
accepted
justify
novel
expansion
impossibility
author
law
review
article
proposing
theory
acknowledges
non
obstante
provision
rejects
artificial
presumption
intend
contradict
state
laws
federal
statutes
must
therefore
harmonized
state
carefully
avoids
discussing
ramifications
new
theory
longstanding
presumption
According
generic
drug
industry
millions
dollars
year
seeking
reassure
consumers
affordable
generic
drugs
really
federal
law
compels
pricier
